Clinical Trial

Pharmacokinetics and Safety Profiles After Administration of DA-5221_01 and Co-administration of 5221_01-R1 and DA-5221_01-R2 in Healthy Adult Volunteers

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated September 27, 2024 (before its estimated November 14, 2024 completion). Its status may not reflect the trial's current state.
Summary
Pharmacokinetics and Safety Profiles After Administration of DA-5221\_01 and Co-administration of 5221\_01-R1 and DA-5221\_01-R2 in Healthy Adult Volunteers
Trial Details
NCT Number NCT06616883
Lead Sponsor Dong-A ST Co., Ltd.
Conditions Healthy
Enrollment 44 participants
Start Date 2024-09-30
Primary Completion 2024-11-14 (estimated)
Study Completion 2024-11-18 (estimated)
Updated on ClinicalTrials.gov 2024-09-27